BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4020835)

  • 41. Synthesis and antitumor evaluation of some nitrosourea and nitrogen mustard amino acid derivatives.
    Rodriguez M; Imbach JL; Martinez J
    J Med Chem; 1984 Sep; 27(9):1222-5. PubMed ID: 6471076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and antitumor activity of 4-[p-[bis(2-chloroethyl)amino]phenyl]butyrates.
    Roehrig GR; Billman JH; Marcec J; Fritz P; Shea F
    J Pharm Sci; 1980 Oct; 69(10):1232-4. PubMed ID: 7420301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computer assisted structure-activity correlations. Evaluation of benzo(de)isoqinoline-1,3-diones and related compounds as antitumor agents.
    Paull KD; Nasr M; Narayanan VL
    Arzneimittelforschung; 1984; 34(10):1243-6. PubMed ID: 6542782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polyamine analogues with antitumor activity.
    Edwards ML; Prakash NJ; Stemerick DM; Sunkara SP; Bitonti AJ; Davis GF; Dumont JA; Bey P
    J Med Chem; 1990 May; 33(5):1369-75. PubMed ID: 2329556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential central nervous system antitumor agents. Aziridinylbenzoquinones.
    Chou F; Khan AH; Driscoll JS
    J Med Chem; 1976 Nov; 19(11):1302-8. PubMed ID: 1003407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimitotic agents: ring analogues and derivatives of ethyl [(S)-5-amino-1,2-dihydro-2-methyl-3-phenylpyrido[3,4-b]pyrazin-7- yl]carbamate.
    Temple C; Rener GA
    J Med Chem; 1992 Dec; 35(26):4809-12. PubMed ID: 1479582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice.
    Hatheway GJ; Hansch C; Kim KH; Milstein SR; Schmidt CL; Smith RN; Quinn FR
    J Med Chem; 1978 Jun; 21(6):563-74. PubMed ID: 671453
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allylic esters as potential antitumor agents. Derivatives and analogues of 2,3-bis(hydroxymethyl)-7-oxabicyclo[2.2.1]hept-2-ene.
    Anderson WK; Dewey RH; Mulumba B
    J Med Chem; 1979 Oct; 22(10):1270-2. PubMed ID: 513076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and cytotoxic evaluation of novel thiazolocarbazoles. Part III.
    Chabane H; Lamazzi C; Thiery V; Pierre A; Leonce S; Pfeiffer B; Renard P; Guillaumet G; Besson T
    J Enzyme Inhib Med Chem; 2003 Apr; 18(2):167-74. PubMed ID: 12943201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain.
    Suster DC; Tărnăuceanu E; Ionescu D; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1162-5. PubMed ID: 722722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and cytotoxic activity of acronycine derivatives modified at the pyran ring.
    Elomri A; Skaltsounis AL; Michel S; Tillequin F; Koch M; Rolland Y; Pierré A; Atassi G
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2165-8. PubMed ID: 8945782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues.
    Driscoll JS; Marquez VE; Plowman J; Liu PS; Kelley JA; Barchi JJ
    J Med Chem; 1991 Nov; 34(11):3280-4. PubMed ID: 1956046
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
    Giorgi-Renault S; Renault J; Gebel-Servolles P; Baron M; Paoletti C; Cros S; Bissery MC; Lavelle F; Atassi G
    J Med Chem; 1991 Jan; 34(1):38-46. PubMed ID: 1992140
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
    Liu MC; Lin TS; Sartorelli AC
    J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential anticancer agents. 17. Analogues of methotrexate with a tripeptide side chain.
    Suster DC; Tărnăuceanu E; Botez G; Dobre V; Niculescu-Duvăz I
    J Med Chem; 1978 Nov; 21(11):1165-7. PubMed ID: 722723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antitumor activity of a series of ftorafur analogues: the effect of varying electronegativity at the 1'-position.
    Holshouser MH; Shipp AM; Ferguson PW
    J Med Chem; 1985 Feb; 28(2):242-5. PubMed ID: 3918171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antineoplastic activity of azacarbazoles. I. Synthesis and antitumor properties of alpha-carboline and its selected derivatives.
    Wieczorek J; Peczyńska-Czoch W; Mordarski M; Kaczmarek L; Nantka-Namirski P
    Arch Immunol Ther Exp (Warsz); 1986; 34(3):315-21. PubMed ID: 3592935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential antitumor agents. 25. Azalogues of the 4'-(9-acridinylamino) methanesulfonanilides.
    Denny WA; Atwell GJ; Cain BF
    J Med Chem; 1977 Oct; 20(10):1242-6. PubMed ID: 903915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.